Alexa

Method developed for improving antibody drug production

Method developed for improving antibody drug production

Kaohsiung, Jan. 7 (CNA) A research team from Kaohsiung Medical University has developed a new genomic reconstruction method called antibody locker that can be widely applied to antibody drugs and has huge business potential, according to team leader Cheng Tien-lu. The new development is expected to aid in constructing more selective "second-generation antibody drugs" to achieve selective target therapy, said Cheng, a professor at the university's Biomedical Science and Environmental Biology Department. The technique, the first of its kind in the world, can be used to produce drugs to kill cancer cells and can reduce side effects caused by these drugs, said Cheng. Cheng said the team has applied for international patent protection, including the Paris Convention Treaty and the Patent Cooperation Treaty, for the technique. It also plans to apply to patent the invention in over 140 countries in 30 months. He added that some domestic and foreign pharmaceutical companies have consulted with the team for transfers of the technology for targeted drug production. Last year, the value of global output of targeted drugs reached US$54 billion. The development is expected to create US$10 billion in economic gains through technology transfer related to medical products and local production, Cheng said. (By Chang Che-fon and Y.L. Kao)


Updated : 2020-12-03 13:19 GMT+08:00